methyl methanesulfonate has been researched along with Fragile X Syndrome in 1 studies
Fragile X Syndrome: A condition characterized genotypically by mutation of the distal end of the long arm of the X chromosome (at gene loci FRAXA or FRAXE) and phenotypically by cognitive impairment, hyperactivity, SEIZURES, language delay, and enlargement of the ears, head, and testes. INTELLECTUAL DISABILITY occurs in nearly all males and roughly 50% of females with the full mutation of FRAXA. (From Menkes, Textbook of Child Neurology, 5th ed, p226)
Excerpt | Relevance | Reference |
---|---|---|
"Thus, dFMRP maintains genome stability under genotoxic stress and regulates the G2/M DNA damage checkpoint by suppressing CycB expression." | 1.38 | Drosophila FMRP participates in the DNA damage response by regulating G2/M cell cycle checkpoint and apoptosis. ( Bi, X; Jiang, F; Liu, W; Zhang, YQ, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, W | 1 |
Jiang, F | 1 |
Bi, X | 1 |
Zhang, YQ | 1 |
1 other study available for methyl methanesulfonate and Fragile X Syndrome
Article | Year |
---|---|
Drosophila FMRP participates in the DNA damage response by regulating G2/M cell cycle checkpoint and apoptosis.
Topics: Animals; Apoptosis; Cyclin B; DNA Damage; Drosophila melanogaster; Drosophila Proteins; Fragile X Me | 2012 |